HER2 (also known as ERBB2/neu) is a tyrosine kinase transmembrane receptor of the plHER family (EGFR/HER1, HER2, HER3, and HER4), which is amplified and/or overexpressed in various cancer types, including early-stage breast cancer. This evidence concerns the gene ERBB2 and breast cancer.